Axsome Therapeutics Inc.

News & Events

Press Releases

In The Media

1. Axsome Therapeutics to Participate in Upcoming Investor Conferences

   GlobeNewswire MAY 29, 2025 7:00 AM EDT
   NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmac...
   READ ARTICLE

2. Axsome Therapeutics Presents Data from Three of Its Innovative Neuroscience Programs at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting

   GlobeNewswire MAY 28, 2025 7:00 AM EDT
   NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmac...
   READ ARTICLE

3. Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Hetero Labs Ltd.

   GlobeNewswire MAY 27, 2025 7:00 AM EDT
   NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a b...
   READ ARTICLE

4. Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss - Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm

   GlobeNewswire MAY 14, 2025 6:30 PM EDT
   SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential viola...
   READ ARTICLE

5. Axsome Therapeutics Enters $570 Million Term Loan and Revolving Credit Facility with Blackstone

   GlobeNewswire MAY 13, 2025 7:00 AM EDT
   Previous term loan facility retired NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Axsome Thera...
   READ ARTICLE

6. Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

   GlobeNewswire MAY 5, 2025 7:00 AM EDT
   Total 1Q 2025 net product revenue of $121.5 million, representing 62% year-over-year growth ...
   READ ARTICLE

7. Axsome Therapeutics and Mental Health America (MHA) Join Voices to Highlight Mental Health Month

   GlobeNewswire MAY 1, 2025 7:00 AM EDT
   NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmac...
   READ ARTICLE

8. Axsome Therapeutics to Participate in Upcoming Investor Conferences

   GlobeNewswire APR 22, 2025 7:00 AM EDT
   NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharm...
   READ ARTICLE

9. SECURITIES FRAUD CLASS ACTIONS HAVE SURVIVED MOTIONS TO DISMISS: Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); and Virtu Financial Inc. (NASDAQ: VIRT) Should Contact Grabar Law Office Today

   GlobeNewswire APR 14, 2025 9:00 AM EDT
   PHILADELPHIA, April 14, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) ...
   READ ARTICLE

10. Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf

    GlobeNewswire APR 11, 2025 9:17 AM EDT
    PHILADELPHIA , April 11, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM)...
    READ ARTICLE